Antithrombotic effects of YS-49 and YS-51 - 1-naphthylmethyl analogs of higenamine

Thrombosis Research

Volumn 104, Issue 4, 2001, Pages 249-255

  Yun Choi, Hye Sook ^a   Pyo, Mi Kyung ^a   Park, Kyung Mi ^a   Chang, Ki Churl ^b   Lee, Duck Hyung ^c  

^a Seoul National University   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Sogang University   (South Korea)

Author keywords

Antiplatelet; Antithrombotic; Tetrahydroisoquinoline; YS 49; YS 51

Indexed keywords

1 (ALPHA NAPHTHYLMETHYL) 6,7 DIHYDROXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 1 (BETA NAPHTHYLMETHYL) 6,7 DIHYDROXY 1,2,3,4 TETRAHYDROISOQUINOLINE; ACETYLSALICYLIC ACID; ACONITUM EXTRACT; ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; HIGENAMINE; METHYL GROUP; UNCLASSIFIED DRUG; YS 49; YS 51;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTERIOVENOUS FISTULA; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; THROMBUS;

ALKALOIDS; ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; HUMANS; INHIBITORY CONCENTRATION 50; ISOQUINOLINES; MICE; MICE, INBRED ICR; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROISOQUINOLINES; THROMBOSIS; TREATMENT OUTCOME;

EID: 0035891545     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00372-3     Document Type: Article

References (21)

1. Studies on cardiac principle in Aconite roots: I. Isolation and structure determination of higenamine
2. Anti-thrombotic effects of higenamine
3. Higenamine reduced mortalities in the mouse models of thrombosis and endotoxic shock
4. Platelet anti-aggregating activities of higenamine analogs
5. Studies on cardiac principle of Aconite root
6. Synthesis of higenamine and its cardiovascular effects in rabbit: Evidence for β-adrenoceptor agonist
7. An experimental study on the adrenergic effect of higenamine in rabbit cadiovascular system
8. Inhibition of activation of nuclear factor κB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of Aconite root
9. Inhibition of lipopolysaccharide-induced inducible nitric oxide(iNOS) mRNA expression and nitric oxide production by higenamine in murine peritoneal macrophages
10. Pharmacological evaluation of GS-389, a novel tetrahydroisoquinoline analog related to higenamine, on vascular smooth muscle
11. Different pharmacological characteristics of structurally similar benzylisoquinoline analogs, papaverine, higenamine, and GS 389, on isolated rat aorta and heart
12. Cardiovascular effect of a naphtylmethyl substituted tetrahydroisoquinoline, YS 49, in rat and rabbit
13. Pharmacological characterization of synthetic tetrahydroisoquinoline alkaloids YS 51 and YS 55, on the cardiovascular system
14. Comparison of inodilator effect of higenamine, YS-49, YS-51, tetrahydroisoquinoline analogs, and Dobutamine in the rat
15. Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS-49, in rat vascular smooth muscle and RAW 264.7 macrophages
16. Inhibition of tumor necrosis factor-α mRNA expression by a limited series of tetrahydroisoquinolines in mouse peritoneal macrophages
17. Epinephrine induced platelet aggregation in platelet rich plasma
18. Mouse antithrombotic assay: A simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol
19. Antiplatelet and antithrombotic effects of a combination of ticlopidine and Ginkgo biloba Ext (Egb 761)
20. Normal platelet function and antiplatelet drugs
21. Platelet-dependent and procoagulant mechanisms in arterial thrombosis